Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
2 clinical trials · Condition
◉ Watch Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma (NCT04848753) | Shanghai Junshi Bioscience Co., Ltd. | 2021-05-12 |
Track Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.